Tirosint Cost in Hawaii 2026: Cash Price, Insurance, Medicaid, and Compounded Alternatives

What Is Tirosint and Why Does It Cost More Than Generic Levothyroxine?

Tirosint is a branded levothyroxine formulation manufactured by IBSA Pharma that comes in a soft gel capsule (Tirosint) and a liquid solution (Tirosint-SOL). Unlike standard levothyroxine tablets, Tirosint contains only four ingredients: levothyroxine sodium, gelatin, glycerin, and water. The absence of acacia, lactose, dyes, and other excipients found in conventional tablets makes it useful for patients with absorption problems, dye sensitivities, or gastrointestinal conditions that interfere with thyroid hormone uptake. [1]

Generic levothyroxine tablets (from Mylan, Lannett, Amneal, and others) are available for $10 to $25 per month at most Hawaii pharmacies. Tirosint carries no FDA-approved generic equivalent as of January 2026, which explains its retail premium of roughly $230 per month. The FDA requires that thyroid hormone products demonstrate bioequivalence within a narrow range; even small formulation differences can shift absorption enough to move TSH out of the target window. The agency's guidance on narrow therapeutic index drugs reinforces why brands like Tirosint remain clinically distinct from tablet generics for certain patients. [2]

Vita et al. (Endocrine, 2014, N=31) showed that switching from levothyroxine tablets to the soft gel capsule formulation produced a statistically significant reduction in TSH (mean TSH fell from 3.69 to 2.75 mIU/L, P<0.01) in patients with chronic autoimmune thyroiditis who were also taking proton pump inhibitors, suggesting better absorption in an acid-suppressed gastric environment. [3] That absorption advantage is part of the clinical rationale physicians cite when writing a brand-necessary prescription that bypasses standard generic substitution.

Thyroid hormone replacement affects an estimated 20 million Americans, according to the American Thyroid Association, and hypothyroidism prevalence is approximately 4.6% in the U.S. population. [4] In Hawaii, where dietary iodine patterns differ from mainland norms due to distinct food traditions, thyroid disease is a common outpatient diagnosis.

Hawaii Cash Price for Tirosint in 2026

The manufacturer's wholesale acquisition cost for Tirosint gel capsules runs approximately $230 per month for a 30-day supply, and that figure holds across Hawaii retail pharmacies in 2026 without insurance or a savings program. [5]

Hawaii has a higher cost of living than most U.S. states, and pharmacy overhead reflects that. Retail prices can vary by $15 to $40 between chains (Longs Drugs, Walmart, Costco, Walgreens) and independent pharmacies in Honolulu, Hilo, Kailua-Kona, and Kahului. Costco's pharmacy in Hawaii has historically offered some of the lowest cash prices on branded drugs because Costco does not markup medications to subsidize front-end retail margins.

Goodrx, RxSaver, and NeedyMeds coupons apply to medications with a generic equivalent or a dispensed-as-written brand that the coupon processor covers. For Tirosint specifically, coupon availability is inconsistent, and the IBSA savings card (see below) typically beats third-party coupons for commercially insured patients. Cash-pay patients without insurance should call three to five Hawaii pharmacies before filling to find the best cash price, since pharmacy acquisition costs vary.

The FDA label for Tirosint (NDA 022405) specifies that the capsules should be stored at controlled room temperature and protected from light and moisture. [6] Pharmacies in humid Hawaii environments should handle storage per label requirements, and patients should confirm their pharmacy complies, since degraded levothyroxine means under-dosing and rising TSH.

Does Hawaii Medicaid Cover Tirosint?

Hawaii Medicaid (Med-QUEST) does not cover Tirosint as of the 2025 published formulary. [7] Med-QUEST managed care plans (Aloha Care, Kaiser Permanente Hawaii, UnitedHealthcare Community Plan, and 'Ohana Health Plan) uniformly require that levothyroxine be dispensed as a generic tablet first. Tirosint requires a prior authorization demonstrating that the patient has a documented clinical reason why a tablet formulation is inadequate.

Prior authorization for Tirosint under Medicaid typically requires: documented malabsorption syndrome, celiac disease, bariatric surgery, lactose intolerance severe enough to cause tablet excipient reactions, or evidence of persistently uncontrolled TSH despite adequate tablet doses. Even with documentation, Med-QUEST plans have denied Tirosint coverage and instead offered a trial of a different generic tablet manufacturer, which some endocrinologists consider clinically equivalent only if the patient switches brands and rechecks TSH at six weeks per standard monitoring practice. [8]

The Endocrine Society's 2014 clinical practice guideline on hypothyroidism states: "We recommend using the same levothyroxine product consistently, whether brand or generic, to minimize the risk of variations in thyroid hormone levels." [9] That recommendation supports prior authorization arguments when a patient has already been stable on Tirosint and a plan tries to force a switch.

If prior authorization is denied, patients have the right to an appeal and an independent medical review under Hawaii insurance law (HRS Chapter 432E). Involving the prescribing physician in a peer-to-peer call with the plan's medical director is often the most efficient path to overturning a denial. [10]

Which Private Insurance Plans Cover Tirosint in Hawaii?

Commercial coverage varies by plan tier and year. Major Hawaii carriers include HMSA (Hawaii Medical Service Association, the state BCBS affiliate), Kaiser Permanente Hawaii, United Healthcare, and Aetna.

HMSA's formulary has placed Tirosint on Tier 3 (preferred brand) in recent years, which means a copay of $50 to $90 per month depending on the specific plan design. [11] Kaiser Permanente Hawaii, which operates a closed network, dispenses levothyroxine through its own pharmacies; Tirosint requires a prior authorization documenting tablet intolerance or absorption failure. United Healthcare's Hawaii commercial plans have listed Tirosint on Tier 2 or Tier 3 depending on the employer group. Aetna's Hawaii plans mirror national formulary structures, placing Tirosint on Tier 3 with step-therapy requirements.

The key variable is whether the employer group has opted for an open or closed formulary. Self-insured employers in Hawaii (common in state government, tourism, and the military contractor sector) set their own formulary rules, and their plans sometimes exclude Tirosint entirely or require step-through two generic failures first.

To check your specific plan's coverage before the prescription is filled: call the member services number on the back of your insurance card, ask for the pharmacy benefit manager (PBM) contact (often Express Scripts, CVS Caremark, or OptumRx for Hawaii groups), and request the formulary tier and any step-therapy requirements for NDC 72162-0001. [12]

How Does the IBSA Savings Card Work in Hawaii?

IBSA Pharma operates a copay assistance program for commercially insured patients, sometimes referred to as the Tirosint Savings Card. Eligible patients may pay as little as $25 per monthly fill, with IBSA covering the remainder up to a defined annual cap.

Eligibility rules that apply in all states including Hawaii: the patient must have commercial (private) insurance, must not be enrolled in any federal or state government insurance program (Medicare Part D, Medicaid, TRICARE, or VA coverage disqualify the patient), and must be a U.S. resident. [13] The savings card is presented at the pharmacy at the time of dispensing. Most major Hawaii retail pharmacies participate.

The HealthRX clinical team built the following decision framework for Hawaii patients trying to choose between paying cash, using insurance, or applying the savings card:

1. Commercially insured with Tirosint on formulary at Tier 3: Use the IBSA savings card to reduce copay to $25.
2. Commercially insured with Tirosint not on formulary: File a prior authorization. If denied, appeal. While appealing, use the savings card at cash-pay price if the plan does not prohibit it.
3. Med-QUEST (Medicaid): Savings card prohibited. File PA, appeal if denied, then evaluate compounded levothyroxine via 503A pharmacy.
4. Medicare Part D: Savings card prohibited. Evaluate Extra Help (Low Income Subsidy) for Part D, or ask prescriber about 503A compounded liquid levothyroxine, which is not a Part D-covered product and can be paid out of pocket without affecting Part D benefit design.
5. Uninsured or underinsured: Compare IBSA cash-pay savings card (if available to uninsured patients under current program terms) against 503A compounded options.

Patients can register for the savings card at IBSA's manufacturer website or ask the pharmacy to process it directly. Program terms change annually; the dollar cap and per-fill maximum should be confirmed at the start of each benefit year. [14]

Is Compounded Levothyroxine Legal in Hawaii, and What Does It Cost?

Compounded levothyroxine in liquid or gel-capsule form is legal in Hawaii when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription from a licensed prescriber. [15]

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies. A 503A pharmacy must operate under a valid prescription for an identified individual patient, use USP-grade active pharmaceutical ingredients, and comply with state pharmacy board standards. The Hawaii Board of Pharmacy (under HRS Chapter 461) licenses compounding pharmacies operating in the state, and out-of-state 503A pharmacies may ship to Hawaii if they are licensed to do business in the state per Hawaii Board of Pharmacy rules. [16]

Compounded levothyroxine does not appear on the FDA's list of drugs that may not be compounded (the "demonstrably difficult to compound" list or the "essentially a copy" list for commercially available products). However, FDA policy does require that compounded versions not be essentially a copy of a commercially available product unless the prescriber documents a clinical difference (such as an allergy to a tablet excipient or a need for a different dose strength not commercially available). [17]

Cost for a compounded levothyroxine liquid or gel capsule from a Hawaii-licensed 503A pharmacy ranges widely, from roughly $30 to $80 per month depending on dose, quantity, and the specific pharmacy's pricing. Some HealthRX affiliate pharmacies have offered compounded levothyroxine oral liquid at costs below $50 per month for Hawaii patients. This is a meaningful reduction from Tirosint's $230 list price.

Quality control is the key clinical concern. Compounded preparations lack the pharmacokinetic consistency data that Tirosint has. Vita et al. specifically studied the IBSA gel capsule formulation, not compounded equivalents, so absorption data from that trial cannot be directly applied to compounded products. [3] Patients switching from Tirosint to a compounded formulation should recheck TSH and free T4 at six weeks, then again at 12 weeks, to confirm equivalent thyroid hormone delivery. The American Thyroid Association recommends TSH monitoring 4 to 6 weeks after any levothyroxine formulation or dose change. [18]

Can You Get a Tirosint Prescription via Telehealth in Hawaii?

Telehealth prescribing of Tirosint is legal in Hawaii. Hawaii was among the states that made pandemic-era telehealth flexibilities permanent through state legislation. [19] A licensed Hawaii prescriber (physician, APRN, or PA with prescribing authority) can conduct a synchronous audio-video visit, evaluate thyroid function labs, and issue a valid Tirosint prescription that any licensed Hawaii pharmacy can fill.

The prescription must still meet standard requirements: patient identity verification, a valid prescriber-patient relationship, and a documented clinical indication. Prescribing levothyroxine by telehealth does not require an in-person physical exam under Hawaii law as long as the clinical standard of care can be met via the telehealth encounter. [20]

HealthRX providers licensed in Hawaii can prescribe Tirosint or compounded levothyroxine following review of recent TSH and free T4 labs. Patients typically need labs drawn within the prior 90 days (or 6 months if stable) for the prescriber to establish a clinical baseline before prescribing.

Why Would a Prescriber Choose Tirosint Over Generic Levothyroxine Tablets?

Generic levothyroxine tablets are the appropriate first-line choice for most patients with hypothyroidism. Clinical practice guidelines from the American Association of Clinical Endocrinology and the American Thyroid Association both support generic levothyroxine as standard care. [9, 21]

Tirosint carries a clinical rationale in specific subgroups. A 2013 study published in Thyroid (Cappelli et al., N=29) found that levothyroxine soft gel capsule produced significantly better TSH normalization than tablets in patients taking calcium carbonate simultaneously, a common supplement interaction that reduces tablet absorption. [22] Patients on proton pump inhibitors (omeprazole, esomeprazole, pantoprazole) also absorb gel-cap levothyroxine better than tablet forms, as shown in the Vita et al. trial (P<0.01 for TSH reduction). [3]

Other indications that may support Tirosint or a liquid formulation: post-bariatric surgery (Roux-en-Y gastric bypass or sleeve gastrectomy reduces gastric acid and alters absorption), celiac disease with partial villous atrophy, lactose intolerance with sensitivity to tablet excipients, and documented tablet dysphagia. The FDA label for Tirosint notes it is indicated for hypothyroidism and as a TSH suppressant in thyroid cancer, identical indications to generic tablets. [6]

Switching from a stable generic tablet regimen to Tirosint without a clinical reason is not recommended by standard guidelines, since the transition itself can transiently destabilize TSH. [9]

Monitoring TSH After Starting or Switching to Tirosint in Hawaii

Starting Tirosint or switching to a compounded levothyroxine alternative requires TSH monitoring at 4 to 6 weeks per Endocrine Society guidelines. [8] The TSH target for most adults with primary hypothyroidism is 0.5 to 2.5 mIU/L, though targets shift for older adults (0.5 to 3.5 or 4.0 mIU/L) and for thyroid cancer survivors on suppression therapy (TSH <0.1 mIU/L in high-risk patients). [9]

Hawaii patients using telehealth for thyroid management should use a local Quest Diagnostics or LabCorp draw site (both operate across Oahu, Maui, Hawaii Island, and Kauai) or a hospital outpatient lab. Quest Diagnostics has eight patient service centers on Oahu alone. [23] Remote island patients may need to coordinate with a community health center for blood draws.

Free T4 should be ordered alongside TSH at every monitoring visit for patients on Tirosint, particularly if the TSH remains outside target despite dose adjustments. Free T3 is not routinely needed unless there is a clinical suspicion of T4-to-T3 conversion problem or the patient has had a thyroidectomy and is on combination therapy. [9]

A 2019 meta-analysis in Frontiers in Endocrinology (Idrees et al.) found that serum TSH variability was significantly lower in patients using liquid levothyroxine compared with tablet formulations across five randomized trials (pooled N=276, mean difference in TSH variance P<0.05). [24] This supports the clinical logic behind Tirosint for patients whose TSH fluctuates despite confirmed tablet adherence.

Practical Cost-Reduction Checklist for Hawaii Tirosint Patients

Step 1: Confirm your insurance tier for Tirosint. Call your PBM or use the plan portal.

Step 2: Apply the IBSA savings card if you are commercially insured and not on a government program.

Step 3: If Medicaid-enrolled and denied, file a prior authorization with documentation of your absorption-impairing condition. Attach the Vita et al. study and the Endocrine Society guideline quote as supporting literature. [3, 9]

Step 4: If cost remains prohibitive after PA and appeal, ask your HealthRX prescriber about a 503A compounded levothyroxine liquid formulation and recheck TSH at six weeks after switching.

Step 5: Use a Hawaii lab (Quest or LabCorp) for follow-up TSH and free T4 at 6 weeks, then every 6 to 12 months once stable. The ATA recommends annual TSH testing for stable hypothyroid patients on a fixed dose. [18]

Step 6: Never abruptly stop levothyroxine. Untreated hypothyroidism carries risks of myxedema coma in severe cases, and even subclinical hypothyroidism (TSH 4.5 to 10 mIU/L) is associated with elevated cardiovascular risk. A 2020 cohort study in JAMA Internal Medicine (Rodondi et al. follow-up data) associated subclinical hypothyroidism with a 20% increased hazard for coronary heart disease events in adults under 65. [25]